Admin, Author at CereVasc | Neurological Disease Device Company

About Admin

This author has not yet filled in any details.
So far Admin has created 21 blog entries.

16 Jul, 2024

CereVasc Announces Appointments of New Directors

Admin2024-07-18T18:46:24+00:00July 16th, 2024|

21 May, 2024

Endovascular Shunting for Communicating Hydrocephalus Using a Biologically Inspired Transdural Cerebrospinal Fluid Valved eShunt® Implant

Admin2024-10-15T17:42:20+00:00May 21st, 2024|Tags: Neurosurgery Clinics of North America|

13 May, 2024

CereVasc Announces $70 Million Series B Financing to Advance its Novel eShunt® System for the Treatment of Normal Pressure Hydrocephalus

Admin2024-05-28T21:41:18+00:00May 13th, 2024|

03 Oct, 2023

CereVasc Announces 30th Patient Treated in Pilot Studies of the eShunt® System to treat Communicating Hydrocephalus

Admin2023-12-20T22:01:46+00:00October 3rd, 2023|

26 Sep, 2023

CereVasc eShunt® System Study Data Presented at Congress of Neurological Surgeons Meeting

Admin2023-11-06T22:49:34+00:00September 26th, 2023|

18 Sep, 2023

CereVasc Receives FDA IDE Approval to Expand its Clinical Study of Patients with Normal Pressure Hydrocephalus Utilizing the Generation 2 eShunt® System

Admin2023-11-06T22:46:27+00:00September 18th, 2023|

13 Sep, 2023

CereVasc eShunt® System Study Data Presented at the European Society of Minimally Invasive Neurological Therapy (ESMINT) Congress in Marseille

Admin2023-11-06T22:43:59+00:00September 13th, 2023|

26 Jun, 2023

CereVasc & LianMedical Announce Corporate Partnership

Admin2023-11-06T22:31:47+00:00June 26th, 2023|

14 Jun, 2023

CereVasc’s Minimally Invasive Central Nervous System Therapy Delivery System Receives Outstanding Presentation Award at American Society of Gene & Cell Therapy Annual Meeting

Admin2023-11-06T22:29:02+00:00June 14th, 2023|

04 May, 2023

CereVasc to Present Data on its Minimally Invasive CNS Delivery System at Upcoming American Society of Gene and Cell Therapy Annual Meeting

Admin2023-11-06T22:08:22+00:00May 4th, 2023|